UK Markets close in 14 mins

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0200+0.0982 (+10.65%)
As of 11:11AM EDT. Market open.
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.2800
52-week low 30.8010
50-day moving average 30.9302
200-day moving average 31.5877

Share statistics

Avg vol (3-month) 3715.14k
Avg vol (10-day) 3186.15k
Shares outstanding 588.85M
Implied shares outstanding 6N/A
Float 850.34M
% held by insiders 148.58%
% held by institutions 13.64%
Shares short (28 Apr 2022) 41.6M
Short ratio (28 Apr 2022) 41.1
Short % of float (28 Apr 2022) 42.55%
Short % of shares outstanding (28 Apr 2022) 41.72%
Shares short (prior month 30 Mar 2022) 4827.86k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Apr 2021
Most-recent quarter (mrq)30 Jan 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-91.33%
Return on equity (ttm)-182.81%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-9.75M
Diluted EPS (ttm)-0.1030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.79M
Total cash per share (mrq)0.13
Total debt (mrq)N/A
Total debt/equity (mrq)0.02
Current ratio (mrq)26.62
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-6.31M
Levered free cash flow (ttm)-2.55M